P2Y 12-receptor antagonist – Novel antagonists of the P2Y12-receptor with antithrombotic effect
Purinergic receptors have been in the focus of drug
discovery for many years. Modulation of P2 receptors in platelets is of paramount importance in regulating platelet function, and, as a consequence, in controlling thrombotic diseases, which are the most common cause of morbidity and mortality in the Western world. The P2Y12-receptor on blood platelets is the target of known antithrombotic drugs (e.g. clopidogrel). The receptor is therefore validated for this therapeutic use. Furthermore, the P2Y12-receptor is expressed in certain parts of the brain, which opens new routes for the treatment of neuroinflammatory and neurodegenerative diseases. This invention provides novel antagonists of the P2Y12- receptor. The disclosed novel compounds show reversible and selective binding to the P2Y12-receptor. The molecules do not require bioactivation. Further the patent application discloses synthesis of the compounds with optimised product yield.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 0
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
STRONG Program Cuts Anxiety Issues in Immigrant and Refugee Students
The first randomized control trial of the school-based intervention called Supporting Transition Resilience of Newcomer Groups (STRONG) shows significant reductions in depression, anxiety and behavior problems among refugee and immigrant…
Physical Function Impairments Linked to Hospital Readmission Among 50+ Adults
Researchers from The Ohio State University Wexner Medical Center and College of Medicine’s School of Health and Rehabilitation Sciences (HRS) recently published a study that found a link between impairments in physical function and…
Study Reveals Exercise Improves Brain Insulin, Helps Prevent Dementia
Study confirms positive effects of exercise on insulin signaling proteins from the brain A study led by scientists at Rutgers University-New Brunswick has shown that specialized cells involved in how…